FDA Inspection 1320102 — Sumanlata Awasthi, MBBS
The FDA completed an inspection of Sumanlata Awasthi, MBBS on May 7, 2026 in Corlim. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Corlim (India)
Additional Details
Clinical BA/BE